CBO of Geneyx, Dave is an innovative, top-performing commercial and product management professional with greater than 20 years of experience working for industry-leading life science companies. His passion for the sciences and their potential to advance human health started early in his career working at Syngenta on some of the first genome-wide sequencing efforts. Following this, he was a member of the team that developed and launched Illumina’s first core technology, and then later returned to manage Illumina’s global array business. He has co-founded and consulted for various organizations in business development, product management, and commercialization. Prior to joining Geneyx Dave led go-to-market and commercialization efforts for the Digital Insights business at QIAGEN. He has a record for developing and executing winning strategies that drive growth and profitability in AMR, EMEA, and APAC regions. His education includes a BS in Biochemistry and Cell Biology from the University of California at San Diego, Studies in Molecular Genetics at Cold Spring Harbor, Developmental Biology at the University of Zurich, and an MBA from the Rady School of Business at the University of California at San Diego.